Henry Schein, Inc. (HSIC) - Company Profile - 2026-04-30

Company Overview

Henry Schein, Inc. (HSIC) is a United States-based provider of health care products and services to office-based dental and medical practitioners worldwide. The company operates through three segments: Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It serves dental practices, laboratories, physician practices, ambulatory surgery centers, government and institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein was founded in 1932 and is headquartered in Melville, New York. The firm employs 25,000 people and maintains its corporate website at https://www.henryschein.com.

Business and Operations

Henry Schein’s operations are organized into three segments:

• Global Distribution and Value-Added Services: This segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, [delivery](https://aksoycapital.com/glossary/delivery.html) units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment. It also provides equipment repair services, non-recourse financial services, continuing education services for practitioners, consulting, and other services, and markets a portfolio of consumable merchandise under its corporate brand.

• Global Specialty Products: This segment engages in manufacturing, marketing, and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products; and other health care-related products and services.

• Global Technology: This segment develops and distributes practice management software, e-services, and other products distributed to health care providers.

The company’s products and services are directed toward dental practices, laboratories, physician practices, ambulatory surgery centers, government and institutional clinics, home health providers, and other alternate care settings. Henry Schein is headquartered in Melville, New York, and traces its origins to 1932.

Fundamental Metrics

• Market cap: $8.56B
• Enterprise value: $13.30B
• P/E (trailing): 22.81
• P/E (forward): 12.68
• P/B: 2.66
• [P/S](https://aksoycapital.com/glossary/price-to-sales-ps.html): 0.65
• PEG: 1.69
• Profit margin: 3.02%
• Operating margin: 5.30%
• ROE: 8.70%
• [ROA](https://aksoycapital.com/glossary/return-on-assets-roa.html): 4.33%
• Debt/Equity: 71.74
• [Current ratio](https://aksoycapital.com/glossary/current-ratio.html): 1.38
• Revenue (TTM): $13.18B
• Revenue growth (YoY): 7.70%
• Earnings growth (YoY): 13.60%
• Free cash flow: $383.00M
• Dividend yield: n/a
• Payout ratio: 0.00%
• Beta: 0.88

Share Structure and Ownership

• Shares outstanding: 114,748,051.00
• Float: 94,903,896.00
• Insider held: 0.82%
• Institutional held: 107.29%
• Short ratio (days to cover): 6.22
• Short % of float: 6.82%

Top institutional holders:

• Kohlberg Kravis Roberts & Co. L.P.: 13.64%
• Vanguard Group Inc: 10.10%
• BlackRock Inc.: 6.06%
• Artisan Partners Limited Partnership: 5.79%
• JPMORGAN CHASE & CO: 4.45%

Trading Activity

• Last close: $74.59 (as of 2026-04-30)
• 1-month change: +1.21%
• 3-month change: -2.97%
• Year-to-date change: -2.90%
• 1-year change: +15.72%
• 52-week high: $89.29
• 52-week low: $61.95
• [Drawdown](https://aksoycapital.com/glossary/drawdown.html) from 52W high: -16.46%
• 30-day average volume: 1,054,240
• 90-day average volume: 1,259,541
• Short ratio (days to cover): 6.22
• Short % of float: 6.82%

Recent Price Action

• Last close: $74.59 (as of 2026-04-30)
• 1-month change: +1.21%
• 3-month change: -2.97%
• Year-to-date change: -2.90%
• 1-year change: +15.72%
• 52-week high: $89.29
• 52-week low: $61.95
• Drawdown from 52W high: -16.46%

Strengths

• Three operating segments (Global Distribution and Value-Added Services; Global Specialty Products; Global Technology) with a global customer base.
• TTM revenue of $13.18B and year-over-year revenue growth of 7.70%.
• Earnings growth year over year of 13.60%.
• Profit margin of 3.02% and operating margin of 5.30%.
• Free cash flow of $383.00M and current ratio of 1.38.
• ROE of 8.70% and ROA of 4.33%.
• Beta of 0.88, indicating lower relative price volatility versus the broader market.
• Substantial institutional ownership (107.29%), with top holders including Kohlberg Kravis Roberts, Vanguard, BlackRock, Artisan Partners, and JPMorgan Chase.
• No dividend yield reported and payout ratio of 0.00%, indicating a non-dividend policy based on the provided data.
• Founded in 1932 and headquartered in Melville, New York, reflecting a long operating history and established market presence.
• Employee base of 25,000, suggesting a sizable distribution and services network.

Considerations

• Valuation metrics show trailing P/E of 22.81 and forward P/E of 12.68, with P/S of 0.65 and P/B of 2.66, and PEG of 1.69.
• Profitability metrics indicate a relatively modest profit margin (3.02%) and operating margin (5.30%) against a large revenue base.
• Debt/Equity is high at 71.74, indicating substantial leverage.
• Current ratio stands at 1.38, signaling modest liquidity cushion.
• Free cash flow reported at $383.00M; payout ratio is 0.00% and dividend yield is n/a, implying no dividend payout based on the data.
• Price history shows a 52-week range of $61.95 to $89.29 and a last close of $74.59, with a 1-year return of 15.72% and a drawdown of 16.46% from the 52-week high.
• Short interest is 6.82% of float with a days-to-cover of 6.22, indicating moderate short-term selling pressure relative to float.
• High institutional ownership (over 100% reported) reflects significant ownership concentration among institutions, complemented by a small insider stake (0.82%).

Summary

Henry Schein, Inc. is a U.S.-based health care products and services provider serving dental and medical practitioners through three segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The company reports trailing revenue of $13.18B with positive YoY growth in revenue (7.70%) and earnings (13.60%), a market cap of $8.56B, and an enterprise value of $13.30B. As of 2026-04-30, the stock closed at $74.59, within a 52-week range of $61.95 to $89.29, with a 1-year return of 15.72%. The fundamentals show moderate profitability, leveraged balance sheet, and notable institutional ownership.